Effect of dual-type oligosaccharides on constipation in loperamide-treated rats

  • Han, Sung Hee ;
  • Hong, Ki Bae ;
  • Kim, Eun Young ;
  • Ahn, So Hyun ;
  • Suh, Hyung Joo
  • Received : 2016.06.02
  • Accepted : 2016.08.12
  • Published : 2016.12.01


BACKDROUND/OBJECTIVE: Constipation is a condition that can result from intestinal deformation. Because humans have an upright posture, the effects of gravity can cause this shape deformation. Oligosaccharides are common prebiotics and their effects on bowel health are well known. However, studies of the physiological functionality of a product that contains both lactulose and galactooligosaccharides are insufficient. We investigated the constipation reduction effect of a dual-type oligosaccharide, Dual-Oligo, in loperamide-treated rats. MATERIALS/METHODS: Dual-Oligo consists of galactooligosaccharides (15.80%) and lactulose (51.67%). Animals were randomly divided into four groups, the normal group (normal), control group (control), low concentration of Dual-Oligo (LDO) group, and high concentration of Dual-Oligo (HDO) group. After 7 days of oral administration, fecal pellet amount, fecal weight, watercontent of fecal were measured. Blood chemistry, short-chain fatty acid (SCFA), gastrointestinal transit ratio and length and intestinal mucosa were analyzed. RESULTS: Dual-Oligo increased the fecal weight, and water content of feces in rats with loperamide-induced constipation. Gastrointestinal transit ratio and length and area of intestinal mucosa significantly increased after treatment with Dual-Oligoin loperamide-induced rats. A high concentration of Dual-Oligo tended to produce more acetic acid than that observed for the control group, and Dual-Oligo affected the production of total SCFA. Bifidobacteria concentration of cecal contents in the high-concentration oligosaccharide (HDO) and low-concentration oligosaccharide (LDO) groups was similar to the result of the normal group. CONCLUSIONS: These results showed that Dual-Oligo is a functional material that is derived from a natural food product and is effective in ameliorating constipation.


Oligosaccharides;Constipation;Loperamide;Gastrointestinal transit;Alcian Blue


  1. Harari D, Gurwitz JH, Minaker KL. Constipation in the elderly. J Am Geriatr Soc 1993;41:1130-40.
  2. Muller-Lissner S, Rykx A, Kerstens R, Vandeplassche L. A doubleblind, placebo-controlled study of prucalopride in elderly patients with chronic constipation. Neurogastroenterol Motil 2010;22:991-8, e255.
  3. Gallagher PF, O'Mahony D, Quigley EM. Management of chronic constipation in the elderly. Drugs Aging 2008;25:807-21.
  4. Kallman H. Constipation in the elderly. Am Fam Physician 1983;27: 179-84.
  5. Faigel DO. A clinical approach to constipation. Clin Cornerstone 2002;4:11-21.
  6. Lacy BE, Brunton SA. Partnering with gastroenterologists to evaluate patients with chronic constipation. MedGenMed 2005;7:19.
  7. Smith B. Effect of irritant purgatives on the myenteric plexus in man and the mouse. Gut 1968;9:139-43.
  8. Smith B. Pathologic changes in the colon produced by anthra quinone purgatives. Dis Colon Rectum 1973;16:455-8.
  9. Ly SY, Cho JH, Lee KA. Effects of fructooligosaccharide and fructooligosaccharide containing sponge cake on blood lipids, intestinal function and short chain fatty acid production in rats. Korean J Nutr 2003;36:344-51.
  10. Yu LL, Liao JF, Chen CF. Anti-diarrheal effect of water extract of Evodiae fructus in mice. J Ethnopharmacol 2000;73:39-45.
  11. Demigne C, Remesy C. Stimulation of absorption of volatile fatty acids and minerals in the cecum of rats adapted to a very high fiber diet. J Nutr 1985;115:53-60.
  12. Guillon F, Champ MM. Carbohydrate fractions of legumes: uses in human nutrition and potential for health. Br J Nutr 2002;88 Suppl 3:S293-306.
  13. Corfield AP, Carroll D, Myerscough N, Probert CS. Mucins in the gastrointestinal tract in health and disease. Front Biosci 2001;6: D1321-57.
  14. Hsieh C. Treatment of constipation in older adults. Am Fam Physician 2005;72:2277-84.
  15. Potter J, Wagg A. Management of bowel problems in older people: an update. Clin Med (Lond) 2005;5:289-95.
  16. Kim HJ, Kim SI, Han YS. Effects of sea tangle extract and sea tangle yogurt on constipation relief. Korean J Food Cookery Sci 2008;24: 59-67.
  17. Wintola OA, Sunmonu TO, Afolayan AJ. The effect of Aloe ferox Mill. in the treatment of loperamide-induced constipation in Wistar rats. BMC Gastroenterol 2010;10:95.
  18. Lee HY, Kim JH, Jeung HW, Lee CU, Kim DS, Li B, Lee GH, Sung MS, Ha KC, Back HI, Kim SY, Park SH, Oh MR, Kim MG, Jeon JY, Im YJ, Hwang MH, So BO, Shin SJ, Yoo WH, Kim HR, Chae HJ, Chae SW. Effects of Ficus carica paste on loperamide-induced constipation in rats. Food Chem Toxicol 2012;50:895-902.
  19. Shimotoyodome A, Meguro S, Hase T, Tokimitsu I, Sakata T. Decreased colonic mucus in rats with loperamide-induced constipation. Comp Biochem Physiol A Mol Integr Physiol 2000;126:203-12.
  20. Huang H, Jiang Q, Chen Y, Li X, Mao X, Chen X, Huang L, Gao W. Preparation, physico-chemical characterization and biological activities of two modified starches from yam (Dioscorea Opposita Thunb.). Food Hydrocoll 2016;55:244-53.
  21. Ait-Aissa A, Aider M. Lactulose: production and use in functional food, medical and pharmaceutical applications. Practical and critical review. Int J Food Sci Technol 2014;49:1245-53.
  22. Sakata T. Stimulatory effect of short-chain fatty acids on epithelial cell proliferation of isolated and denervated jejunal segment of the rat. Scand J Gastroenterol 1989;24:886-90.
  23. Frankenhaeuser M. Behavior and circulating catecholamines. Brain Res 1971;31:241-62.
  24. Sin HJ, Kim KO, Kim SH, Kim YA, Lee HS. Effect of resistant starch on the large bowel environment and plasma lipid in rats with loperamide-induced constipation. J Korean Soc Food Sci Nutr 2010;39:684-91.
  25. Thompson DB. Strategies for the manufacture of resistant starch. Trends Food Sci Technol 2000;11:245-53.
  26. Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 1995;125:1401-12.
  27. Cummings JH, Macfarlane GT, Drasar BS. The gut microflora and its significance. In: Whitehead R, editor. Gastrointestinal and Oesophageal Pathology. Edinburgh: Churchill Livingstone; 1989. p. 201-19.
  28. Tancrede C. Role of human microflora in health and disease. Eur J Clin Microbiol Infect Dis 1992;11:1012-5.
  29. Mutai M, Tanaka R. Ecology of Bifidobacterium in the human intestinal flora. Bifidobact Microflora 1987;6:33-41.
  30. Bezkorovainy A, Miller-Catchpole R. Biochemistry and Physiology of Bifidobacteria. Boca Raton (FL): CRC press; 1989.
  31. Hong KB, Suh HJ, Kim JH, Kwon HK, Park C, Han SH. Preparation of high purity galacto-oligosaccharide and its prebiotic activity in vitro evaluation. Korean J Food Nutr 2015;28:1026-32.

Cited by

  1. Manipulation of intestinal dysbiosis by a bacterial mixture ameliorates loperamide-induced constipation in rats vol.9, pp.3, 2018,
  2. Complex-oligosaccharide composed of galacto-oligosaccharide and lactulose ameliorates loperamide-induced constipation in rats vol.27, pp.3, 2018,
  3. Prophylactic use of probiotic chocolate modulates intestinal physiological functions in constipated rats pp.00225142, 2019,


Grant : 저탄소·신가공

Supported by : (주)네오크레마